We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Sarepta Therapeutics Inc
17 own
24 watching
Current Price
$124.47
$1.31
(1.06%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
10,924.26M
52-Week High
134.08
52-Week Low
61.28
Average Volume
0.95M
Dividend Yield
--
P/E Ratio
--
Market Capitalization10,924.26M52-Week High134.0852-Week Low61.28Average Volume0.95MDividend Yield--P/E Ratio--What does the Sarepta Therapeutics Inc do?
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD), which is a rare genetic muscle-wasting disease caused by the absence of dystrophin. It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. The company has a strategic alliance with Nationwide Children's Hospital for the advancement of microdystrophin gene therapy program under the research and option agreement, as well as Galgt2 gene therapy program under the license agreement; Catabasis Pharmaceuticals, Inc to explore a combination drug treatment approach for DMD under the research collaboration agreement; and Charley's Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies under the research agreement. It also has a license agreement with the University of Western Australia for treatment of DMD by inducing the skipping of certain exons; and collaboration and license agreement with Summit (Oxford) Ltd. for the development of ezutromid, an utrophin modulator which is in phase II clinical trials for the treatment of DMD. The company distributes its products through a network of specialty distributors and specialty pharmacies in the United States. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Sarepta Therapeutics Inc make?
News & Events about Sarepta Therapeutics Inc.
Globe Newswire
24days ago
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, ...
PR Newswire
2 months ago
Thinking about trading options or stock in Axsome Therapeutics, Sarepta Therapeutics, Las Vegas Sands, Apple, or Microsoft? Thinking about trading options or stock in Axsome Therapeutics, Sarepta Therapeutics, Las Vegas Sands, Apple, or Microsoft? PR Newswire NEW YORK, Nov. 28, 2022 NEW YORK, Nov...
Globe Newswire
2 months ago
Regulatory action date of May 29, 2023 SRP-9001 would be the first gene therapy for Duchenne, a one-time treatment designed to treat the underlying cause of DMD by delivering a functional shortened dystrophin to muscle CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, ...
Globe Newswire
3 months ago
CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2022 financial results after the Nasdaq Global Market closes on Wednesday, November 2, 2022. Subsequently, at 4:30 p.m. ...
Frequently Asked Questions
Frequently Asked Questions
What is Sarepta Therapeutics Inc share price today?
Can Indians buy Sarepta Therapeutics Inc shares?
How can I buy Sarepta Therapeutics Inc shares from India?
Can Fractional shares of Sarepta Therapeutics Inc be purchased?
What are the documents required to start investing in Sarepta Therapeutics Inc stocks?
What is today’s traded volume of Sarepta Therapeutics Inc?
What is today’s market capitalisation of Sarepta Therapeutics Inc?
What is the 52-Week High and Low Range of Sarepta Therapeutics Inc?
What percentage is Sarepta Therapeutics Inc down from its 52-Week High?
What percentage is Sarepta Therapeutics Inc up from its 52-Week Low?
Current Price
$124.47
$1.31
(1.06%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.